Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity
Transformative Financing worth up to $275 million from Top-Tier Institutional Healthcare Investors ---- Advancement of IkT-001Pro into a ...
snmjournals.org2 小时
Precision Oncology in Melanoma: Changing Practices
Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...